Genetic counseling and testing for BRCA1 and BRCA2 gene mutation has become an integral part of high-risk patient evaluation and management for hereditary breast ovarian cancer [11, 33]. Here, BRCA2 is linked to Hereditary breast and ovarian cancer syndrome.